Ascendis’s ‘takeover consortium’ slated for buying shares without disclosure of interests

By Edward West | Published Jun 20, 2024

Smit said the amount of in-concert trading was big, as the consortium buying out Ascendis had effectively bought some 116 million Ascendis shares through insider trading, that had started in 2021. “We won’t sleep until these people are behind bars,” he said.